$2.5 Billion is the total value of DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C)'s 99 reported holdings in Q4 2018. The portfolio turnover from Q3 2018 to Q4 2018 was 47.7% .
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| XENT | Sell | INTERSECT ENT INC | $58,569,000 | -5.2% | 2,078,375 | -3.2% | 2.34% | +6.0% |
| AERI | Sell | AERIE PHARMACEUTICALS INC | $54,821,000 | -42.2% | 1,518,596 | -1.4% | 2.19% | -35.4% |
| ARGX | Sell | ARGENX SEsponsored adr | $45,345,000 | -8.9% | 472,000 | -28.1% | 1.82% | +1.8% |
| EHTH | Sell | EHEALTH INC | $41,355,000 | +19.3% | 1,076,402 | -12.3% | 1.66% | +33.3% |
| Sell | KEMPHARM INCnote 5.500% 2/0 | $39,363,000 | -18.5% | 65,423,000 | -12.8% | 1.58% | -8.8% | |
| PTLA | Sell | PORTOLA PHARMACEUTICALS INC | $32,743,000 | -49.9% | 1,677,414 | -31.7% | 1.31% | -44.0% |
| Sell | WRIGHT MED GROUP N Vnote 2.250%11/1 | $32,195,000 | -29.4% | 23,625,000 | -25.0% | 1.29% | -21.0% | |
| BKD | Sell | BROOKDALE SR LIVING INC | $28,414,000 | -38.6% | 4,240,855 | -9.9% | 1.14% | -31.4% |
| GKOS | Sell | GLAUKOS CORP | $28,310,000 | -23.4% | 504,000 | -11.5% | 1.13% | -14.4% |
| BPMC | Sell | BLUEPRINT MEDICINES CORP | $28,087,000 | -31.5% | 521,000 | -0.8% | 1.12% | -23.4% |
| SEM | Sell | SELECT MED HLDGS CORP | $21,227,000 | -24.4% | 1,382,890 | -9.4% | 0.85% | -15.5% |
| ACHC | Sell | ACADIA HEALTHCARE COMPANY IN | $15,966,000 | -68.2% | 621,000 | -56.4% | 0.64% | -64.4% |
| ARVN | Sell | ARVINAS INC | $11,838,000 | -43.1% | 921,234 | -25.3% | 0.47% | -36.5% |
| CTMX | Sell | CYTOMX THERAPEUTICS INC | $9,400,000 | -30.4% | 622,548 | -14.7% | 0.38% | -22.3% |
| RYTM | Sell | RHYTHM PHARMACEUTICALS INC | $7,822,000 | -26.7% | 291,005 | -20.4% | 0.31% | -18.1% |
| SYBX | Sell | SYNLOGIC INC | $7,765,000 | -60.0% | 1,107,643 | -18.9% | 0.31% | -55.3% |
| AUTL | Sell | AUTOLUS THERAPEUTICS PLCspon ads | $7,736,000 | +0.9% | 235,576 | -5.8% | 0.31% | +12.7% |
| ARDX | Sell | ARDELYX INC | $5,304,000 | -65.1% | 2,962,922 | -15.1% | 0.21% | -61.0% |
| BIOS | Sell | BIOSCRIP INC | $2,738,000 | -13.7% | 767,000 | -25.1% | 0.11% | -3.5% |
| NVTRQ | Sell | NUVECTRA CORP | $2,108,000 | -65.6% | 129,000 | -53.7% | 0.08% | -61.8% |
| ALPN | Sell | ALPINE IMMUNE SCIENCES INC | $1,750,000 | -54.9% | 475,450 | -22.4% | 0.07% | -49.6% |
| RMED | Sell | RA MED SYS INC | $862,000 | -63.2% | 108,400 | -15.7% | 0.04% | -58.3% |
| MLNT | Sell | MELINTA THERAPEUTICS INC | $265,000 | -97.1% | 333,902 | -85.6% | 0.01% | -96.6% |
| PTXTQ | Exit | PERNIX THERAPEUTICS HLDGS IN | $0 | – | -658,826 | -100.0% | -0.02% | – |
| FOMX | Exit | FOAMIX PHARMACEUTICALS LTD | $0 | – | -234,745 | -100.0% | -0.05% | – |
| TLGT | Exit | TELIGENT INC NEW | $0 | – | -708,873 | -100.0% | -0.10% | – |
| ALBO | Exit | ALBIREO PHARMA INC | $0 | – | -120,000 | -100.0% | -0.14% | – |
| EIDX | Exit | EIDOS THERAPEUTICS INC | $0 | – | -420,409 | -100.0% | -0.15% | – |
| VKTX | Exit | VIKING THERAPEUTICS INC | $0 | – | -460,000 | -100.0% | -0.29% | – |
| QURE | Exit | UNIQURE NV | $0 | – | -241,430 | -100.0% | -0.32% | – |
| BLUE | Exit | BLUEBIRD BIO INC | $0 | – | -61,435 | -100.0% | -0.32% | – |
| BHVN | Exit | BIOHAVEN PHARMACTL HLDG CO L | $0 | – | -239,000 | -100.0% | -0.32% | – |
| ALLK | Exit | ALLAKOS INC | $0 | – | -225,000 | -100.0% | -0.36% | – |
| NITE | Exit | NIGHTSTAR THERAPEUTICS PLCadr | $0 | – | -499,747 | -100.0% | -0.37% | – |
| GTHX | Exit | G1 THERAPEUTICS INC | $0 | – | -287,000 | -100.0% | -0.54% | – |
| AIMT | Exit | AIMMUNE THERAPEUTICS INC | $0 | – | -553,000 | -100.0% | -0.54% | – |
| ZBH | Exit | ZIMMER BIOMET HLDGS INC | $0 | – | -121,000 | -100.0% | -0.57% | – |
| OXFD | Exit | OXFORD IMMUNOTEC GLOBAL PLC | $0 | – | -1,087,359 | -100.0% | -0.63% | – |
| EPZM | Exit | EPIZYME INC | $0 | – | -1,779,094 | -100.0% | -0.68% | – |
| RGNX | Exit | REGENXBIO INC | $0 | – | -275,000 | -100.0% | -0.74% | – |
| AGIO | Exit | AGIOS PHARMACEUTICALS INC | $0 | – | -348,200 | -100.0% | -0.96% | – |
| Exit | K2M GROUP HLDGS INCnote 4.125% 8/1 | $0 | – | -20,000,000 | -100.0% | -1.08% | – | |
| ECYT | Exit | ENDOCYTE INC | $0 | – | -3,514,084 | -100.0% | -2.24% | – |
| DBVT | Exit | DBV TECHNOLOGIES S Asponsored adr | $0 | – | -2,900,000 | -100.0% | -2.33% | – |
Other managers
Other managers that, in addition to the filing manager(s), that filed the EDGAR filing(s):
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2019-02-14
Top long-term holdings
| Name | Quarters owned | Latest quarter owned | Max weighting |
|---|---|---|---|
| AERIE PHARMACEUTICALS INC | 36 | Q3 2022 | 3.6% |
| CENTENE CORP DEL | 33 | Q2 2024 | 3.3% |
| BIOCRYST PHARMACEUTICALS INC | 32 | Q2 2024 | 2.2% |
| MOLINA HEALTHCARE INC | 27 | Q2 2024 | 1.7% |
| BROOKDALE SR LIVING INC | 26 | Q2 2024 | 2.2% |
| EHEALTH INC | 25 | Q3 2020 | 2.0% |
| INTERCEPT PHARMACEUTICALS IN | 24 | Q1 2023 | 2.2% |
| DECIPHERA PHARMACEUTICALS IN | 24 | Q1 2024 | 2.0% |
| MYLAN NV | 23 | Q3 2020 | 6.2% |
| PORTOLA PHARMACEUTICALS INC | 23 | Q1 2019 | 6.0% |
View DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C)'s complete holdings history.
Latest significant ownerships (13-D/G)
| Filed | Shares | Percentage | |
|---|---|---|---|
| DA32 Life Science Tech Acquisition Corp. | August 01, 2023 | 5,145,000 | 91.1% |
| CareMax, Inc. | March 13, 2023 | 18,691,423 | 16.4% |
| CareMax, Inc. | June 02, 2022 | 18,691,423 | 20.7% |
View DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C)'s complete significant-ownership history.
Latest filings
| Type | Filed |
|---|---|
| 4 | 2024-09-17 |
| 3 | 2024-09-12 |
| N-PX | 2024-08-29 |
| 13F-HR | 2024-08-14 |
| 4 | 2024-07-17 |
| 4 | 2024-07-15 |
| 4 | 2024-07-11 |
| 4 | 2024-06-14 |
| 4 | 2024-06-03 |
| 13F-HR | 2024-05-15 |
View DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C)'s complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.